title: [Features of antiagregant and anticoagulant therapy at a hybrid revascularization of a myocardium in elderly and senile patients].
abstract: The hybrid revascularization of a myocardium combines advantages of mammaro-coronary shunting and stenting of coronary arteries and represents the perspective direction in coronary heart disease treatment. This technique is of most value in patients of advanced and senile age, and also in patients of high surgical risk as it shows small injury, which enables to reduce and facilitate the postoperative period. However today, there is no single standard for the execution of these operations, in particular it is not clear, which scheme of antiagregant and anticoagulant therapy is worth adhering for greater efficiency of the procedures and patient safety.
authors.forename: G G
authors.initials: GG
authors.lastname: Khubulava
authors.forename: K L
authors.initials: KL
authors.lastname: Kozlov
authors.forename: S S
authors.initials: SS
authors.lastname: Mikhaĭlov
authors.forename: A N
authors.initials: AN
authors.lastname: Shishkevich
authors.forename: I B
authors.initials: IB
authors.lastname: Oleksiuk
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D017023:Coronary Angiography; D006801:Humans; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D009204:Myocardial Revascularization / Q000379:methods*; D017063:Outcome Assessment, Health Care; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors